SinTS has created a favorable accuracy for patient triage, particularly for patients with high-risk complaints such as chest pain and dyspnea, by using specific criteria of SpO2 and PEF for COPD patients, PetCO2 for HF patients, and cTnI for MI patients. This evidence concerns the gene TNNI3 and hydrops fetalis.